The Latest in Respiratory Care & Innovation
Stay informed with the latest news, research, and product updates from Monaghan Medical. Our commitment to advancing respiratory care drives us to develop innovative aerosol drug delivery devices and asthma management solutions that improve patient outcomes. Here, you’ll find expert insights, clinical studies, and industry updates to help healthcare professionals and patients stay ahead in respiratory health. Explore our news articles to learn about breakthrough technologies, upcoming events, and Monaghan Medical’s contributions to the future of respiratory care.
Supporting Innovation in Asthma Care: New NIH-Funded Study Advances School-Based Management
A newly awarded $4.1 million research grant from the National Institutes of Health (NIH) is set to improve how children with asthma receive care at school. Led by Dr. Marina Reznik of Montefiore Medical Center and Albert Einstein College of Medicine, the study aims to streamline communication among caregivers, clinicians, and schools — making it...
Monaghan Medical and Children’s Hospital Association join forces to improve patient outcomes
Monaghan Medical Corporation (Monaghan) and Children’s Hospital Association (CHA) today announce their agreement to a three-year contract creating a partnership between two industry leaders.
Read the post:Monaghan Medical and Children’s Hospital Association join forces to improve patient outcomesMonaghan Medical Corporation Recognized for Superior Products and Services
The American Association for Respiratory Care honors MMC with its 2021 Zenith Award PLATTSBURGH, N.Y., Sept. 02, 2021 — Monaghan Medical Corporation (MMC), a leader in the development, manufacture, and marketing of respiratory devices including the AeroChamber Plus® Flow-Vu® VHC, AeroEclipse® II Nebulizer, and Aerobika® Oscillatory Pep Device, is the recipient of the 2021 Zenith Award presented by the American […]
Read the post:Monaghan Medical Corporation Recognized for Superior Products and ServicesThe American Association for Respiratory Care honors MMC with its 2021 Zenith Award
Monaghan Medical Corporation (MMC), a leader in the development, manufacture, and marketing of respiratory devices including the AeroChamber Plus® Flow-Vu® VHC, AeroEclipse® II Nebulizer, and Aerobika® Oscillatory Pep Device, is the recipient of the 2021 Zenith Award presented by the American Association for Respiratory Care (AARC). It is the seventh consecutive year MMC has received this prestigious honor. The Zenith Award […]
Read the post:The American Association for Respiratory Care honors MMC with its 2021 Zenith AwardWith Monaghan Medical, Safe Nebulizer Therapy is Possible
Nebulizer therapy is a common treatment for many pulmonary respiratory conditions. However, passive inhalation of exhaled emissions including patient viruses may pose a potential risk to frontline staff safety.1 To date, there is a lack of data available to determine whether nebulization may generate or spread potentially infectious aerosols2, so it is important to take every […]
Read the post:With Monaghan Medical, Safe Nebulizer Therapy is PossibleMonaghan Medical Corporation Receives Zenith Award from American Association of Respiratory Care for Sixth Consecutive Year
PLATTSBURGH, NY (November 24, 2020)—Monaghan Medical Corporation (Monaghan Medical) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the sixth consecutive year. The award is presented annually by the AARC based on ballots cast by respiratory therapists, and receipt of the 2020 Zenith Award deemed even more meaningful as Monaghan’s products […]
Read the post:Monaghan Medical Corporation Receives Zenith Award from American Association of Respiratory Care for Sixth Consecutive YearAdherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory company
Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in the United States. […]
Read the post:Adherium introduces Hailie® technology into specialist USA respiratory centres with leading USA respiratory companyMonaghan Medical Corporation Opens New State-of-the-Art Manufacturing Facility in Plattsburgh, New York
New headquarters building doubles the operational size and is designed to place workers’ safety first during the COVID-19 pandemic PLATTSBURGH, NY (November 5, 2020) – Monaghan Medical Corporation (MMC) today announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building. The new facility will house Monaghan Medical’s warehouse, […]
Read the post:Monaghan Medical Corporation Opens New State-of-the-Art Manufacturing Facility in Plattsburgh, New YorkMonaghan Medical Corporation signs a Letter of Intent to enter into US sales agreement with Adherium, a global leader in digital respiratory health technologies
PLATTSBURGH, NY – 29 April 2020: Monaghan Medical Corporation today announced it has signed a letter of intent to enter into a sales agreement with Adherium Limited (ASX:ADR), a provider of digital health solutions for remote monitoring and data management. The partnership will combine Monaghan’s knowledge and expertise in improving patient outcomes through innovative respiratory […]
Read the post:Monaghan Medical Corporation signs a Letter of Intent to enter into US sales agreement with Adherium, a global leader in digital respiratory health technologiesMonaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment Option
Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika® oscillatory positive expiratory pressure (OPEP) device and the VersaPAP® positive airway pressure device—to create a low cost, safe and effective “tandem therapy”.
Read the post:Monaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment OptionMonaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care
Award recognizes MMC’s outstanding respiratory products and services, and commitment to excellence.
Read the post:Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care